Literature DB >> 6176315

Scirrhous argyrophil cell carcinoma of the stomach with multiple production of polypeptide hormones, amine, CEA, lysozyme, and HCG.

E Tahara, H Ito, K Nakagami, F Shimamoto, M Yamamoto, K Sumii.   

Abstract

Sixteen argyrophil cell carcinomas in 59 gastric scirrhous carcinomas were examined histologically, ultrastructurally, and immunohistochemically for polypeptide hormones, CEA, lysozyme, and HCG. In nine of these 16 tumors, polypeptides such as gastrin, somatostatin, and glucagon were demonstrated. Six of these nine tumors contained all three hormones, and three of these six tumors also had argentaffin cells. In all of these 16 tumors CEA were observed. Eight of them had CEA, lysozyme, and acid mucin synchronously. Of the above six tumors containing three peptides, three produced focal HCG. Ultrastructurally, several types of secretory granules were noted. Histologically, these 16 tumors showed poorly differentiated adenocarcinomas or signet ring cell carcinomas. Macroscopically, generalized type was 11 and localized type five. No hormonal syndrome was detected in any of the patients. It was suggested that these scirrhous argyrophil cell carcinomas of the stomach with the multifunction originate from totipotent immature cells of endodermal origin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176315     DOI: 10.1002/1097-0142(19820501)49:9<1904::aid-cncr2820490925>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  29 in total

1.  Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component.

Authors:  J P Brouland; P Manivet; I Brocheriou-Spelle; M Wassef; M F Le Bodic; A Lavergne; J M Launay
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 2.  Hormonal control of gastric and colorectal cancer in man.

Authors:  D L Morris; S A Watson; L G Durrant; J D Harrison
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

3.  Serotonin in tubular adenomas, adenocarcinomas and endocrine tumours of the stomach. An immunohistochemical study.

Authors:  H Ito; J Hata; N Oda; S Miyamori; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 4.  Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms.

Authors:  Stefano La Rosa; Fausto Sessa; Silvia Uccella
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

5.  The significance of immunochemically staining calcitonin and CEA in fine-needle aspiration biopsy materials from medullary carcinoma of the thyroid.

Authors:  N Takeichi; H Ito; H Okamoto; T Matsuyama; E Tahara; K Dohi
Journal:  Jpn J Surg       Date:  1989-11

6.  The correlation of epidermal growth factor with invasion and metastasis in human gastric cancer.

Authors:  M Onda; A Tokunaga; K Nishi; T Yoshiyuki; Y Shimizu; T Kiyama; T Mizutani; N Matsukura; N Tanaka; K Yamashita
Journal:  Jpn J Surg       Date:  1990-05

7.  Distribution of collagen types I and III and basal lamina in human gastric carcinoma: an immunohistochemical and electron microscopic study.

Authors:  M Yamamoto; H Sumiyoshi; K Nakagami; K Taniyama; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

8.  Glicentin-containing cells in intestinal metaplasia, adenoma and carcinoma of the stomach.

Authors:  H Ito; H Yokozaki; J Hata; K Mandai; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

9.  Immunohistochemical analysis of gastrointestinal carcinoids.

Authors:  H Hayashi; M Nakagawa; S Kitagawa; T Yamada; K Ishida; H Kurumaya
Journal:  Gastroenterol Jpn       Date:  1993-08

10.  Composite carcinoid-adenocarcinoma tumor of the stomach: report of a case.

Authors:  S Nagaoka; H Toyoshima; T Bandoh; T Isoyama; D Kasahara; K Kusafuka; T Takemura; N Tanaka
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.